The latest news and breakthrough developments from the field of cancer research. We bring you the latest updates from organisations looking into diagnosing and treating all types of cancers using the latest scientific advancements and what is being done to improve patient care.
The UK Radon Association is urgently calling on the Government to launch a national campaign addressing exposure to radon gas, an invisible, cancer-causing threat responsible for thousands of preventable lung cancer cases across the UK.
World Cancer Research Fund International (WCRFI) is a not-for-profit organisation that leads a network of cancer prevention charities, including the American Institute for Cancer Research, World Cancer Research Fund in the UK, Wereld Kanker Onderzoek Fonds in the Netherlands and World Cancer Research Fund Hong Kong. They are dedicated to funding research on cancer, specifically how diet, weight, and physical activity affect cancer risk and survival.
The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis, as the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to its new artificial intelligence-powered companion diagnostic device, the VENTANA® TROP2 (EPR20043) RxDx.
Patients are set to benefit from advanced technology that significantly enhances bowel cancer diagnosis, potentially reducing the need for invasive procedures.
Researchers from the University of Cambridge and the NIHR Cambridge Biomedical Research Centre have created an algorithm that finds vulnerable cancer tumours.
Research institutes have committed £5.5 million in funding for a world-leading research team tasked with making personalised medicines for bowel cancer patients.
In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.
Researchers have revealed a new finding that could improve cancer care immunotherapy treatments, particularly for chronic lymphocytic leukaemia (CLL) and other cancers.
